Aclaris Therapeutics, Inc. (ACRS)
NASDAQ · Healthcare
Aclaris Therapeutics, Inc. Net Income 2017–2025
Aclaris Therapeutics, Inc. annual/quarterly net income history and growth rate from 2017 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Aclaris Therapeutics, Inc. net income for the quarter ending March 31, 2026 was -19.8 M, a 31.42% increase year-over-year.
- Aclaris Therapeutics, Inc. net income for the twelve months ending March 31, 2026 was -65.0 M, a 0.27% increase year-over-year.
- Aclaris Therapeutics, Inc. annual net income for 2025 was -64.9 M, a 50.84% decrease from 2024.
- Aclaris Therapeutics, Inc. annual net income for 2024 was -132.1 M, a 49.26% increase from 2023.
- Aclaris Therapeutics, Inc. annual net income for 2023 was -88.5 M, a 1.81% increase from 2022.
- Aclaris Therapeutics, Inc. annual net income for 2022 was -86.9 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aclaris Therapeutics, Inc. Net Income — FAQ
Aclaris Therapeutics, Inc. (ACRS) net income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Aclaris Therapeutics, Inc.'s net income?
Aclaris Therapeutics, Inc. (ACRS) reported net income of -$65M for fiscal 2025.
Where can I see ACRS's net income history?
The chart and table above show Aclaris Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.